Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes.

MLA

Siedlecki, Jakob, et al. “Combined VEGF/PDGF Inhibition Using Axitinib Induces ΑSMA Expression and a pro-Fibrotic Phenotype in Human Pericytes.” Graefe’s Archive of Clinical & Experimental Ophthalmology, vol. 256, no. 6, June 2018, pp. 1141–49. EBSCOhost, https://doi.org/10.1007/s00417-018-3987-8.

APA

Siedlecki, J., Asani, B., Wertheimer, C., Hillenmayer, A., Ohlmann, A., Priglinger, C., Priglinger, S., Wolf, A., & Eibl-Lindner, K. (2018). Combined VEGF/PDGF inhibition using axitinib induces αSMA expression and a pro-fibrotic phenotype in human pericytes. Graefe’s Archive of Clinical & Experimental Ophthalmology, 256(6), 1141–1149. https://doi.org/10.1007/s00417-018-3987-8

Chicago

Siedlecki, Jakob, Ben Asani, Christian Wertheimer, Anna Hillenmayer, Andreas Ohlmann, Claudia Priglinger, Siegfried Priglinger, Armin Wolf, and Kirsten Eibl-Lindner. 2018. “Combined VEGF/PDGF Inhibition Using Axitinib Induces ΑSMA Expression and a pro-Fibrotic Phenotype in Human Pericytes.” Graefe’s Archive of Clinical & Experimental Ophthalmology 256 (6): 1141–49. doi:10.1007/s00417-018-3987-8.